Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels

Francesco Libotte, Maria Rosaria Ricciardi, Elisabetta Calabrese, Cinzia De Benedictis, Sara Santinelli, Paola Bergamo, Samantha Decandia, Anna Levi, Ali Fathi Mohamad, Vincenzo Federico, Michele Milella, Robert Foà, Agostino Tafuri, Maria Teresa Petrucci

Blood (2008) 112 (11): 5159.

https://doi.org/10.1182/blood.V112.11.5159.5159

Published: 2008

Journal Articles

Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways

Maria Rosaria Ricciardi, Michele Milella, Francesco Libotte, Elisabetta Calabrese, Paola Bergamo, Sara Santinelli, Samantha Decandia, Cinzia De Benedictis, Anna Levi, Robert Foà, Agostino Tafuri, Maria Teresa Petrucci

Blood (2008) 112 (11): 5161.

https://doi.org/10.1182/blood.V112.11.5161.5161

Published: 2008

Journal Articles

Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)

Maria Rosaria Ricciardi, PhD, Samantha Decandia, Sara Santinelli, Chiara Gregorj, Fabiana De Cave, Maria Cristina Scerpa, PhD, Paola Bergamo, MS, Francesco Libotte, Cinzia De Benedictis, Antonella Vitale, Maria Teresa Petrucci, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Michele Milella, Robert Foa, Agostino Tafuri

Blood (2008) 112 (11): 5034.

https://doi.org/10.1182/blood.V112.11.5034.5034

Published: 2008

Journal Articles

The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.

Maria Rosaria Ricciardi, PhD, Chiara Gregorj, PhD, Fabiana De Cave, MS, Paola Bergamo, Samantha Decandia, MS, Sara Santinelli, Antonella Vitale, MD, Maria Teresa Petrucci, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD

Blood (2007) 110 (11): 155.

https://doi.org/10.1182/blood.V110.11.155.155

Published: 2007

Journal Articles

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Maria Rosaria Ricciardi, PhD, Elisabetta Calabrese, MD, Fabiana De Cave, PhD, Sara Santinelli, Paola Bergamo, Samantha Decandia, PhD, Chiara Gregorj, PhD, Vincenzo Federico, MD, Michele Milella, MD, Robert Foa, MD, Agostino Tafuri, MD, Maria Teresa Petrucci, MD

Blood (2007) 110 (11): 4782.

https://doi.org/10.1182/blood.V110.11.4782.4782

Published: 2007

Journal Articles

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Blood (2007) 110 (11): 2802.

https://doi.org/10.1182/blood.V110.11.2802.2802

Published: 2007

Journal Articles

Protein Expression and Methylation Status of the CKI p21, p15 and p16 in Adult Acute Lymphoblastic Leukemia (ALL) Patients: Prognostic Implications.

Chiara Gregorj, PhD, Fabiana De Cave, MS, Maria Teresa Petrucci, MD, Maria R. Ricciardi, PhD, Maria C. Scerpa, MS, Sara Santinelli, Vincenzo Liso, MD, Rosario Giustolisi, MD, Andrea Camera, MD, Eugenio Gallo, MD, Felicetto Ferrara, MD, Francesco Nobile, MD, Nicola Cascavilla, MD, Francesco Fabbiano, MD, Giuseppe Leone, MD, Omar Perbellini, MD, Patrizio Mazza, MD, Luciana Annino, MD, Piero Galieni, MD, Eustachio Miraglia, MD, Massimo Martelli, MD, Giuseppe Torelli, MD, Nicola Cantore, MD, Antonio Peta, MD, Alfonso M. D’Arco, MD, Alessandra Tedeschi, MD, Giuseppe Fioritoni, MD, Antonio Cuneo, MD, Maura Brugiatelli, MD, Gianluca Gaidano, MD, PhD, Giuseppe Visani, MD, Ignazio Majolino, MD, Rosa Nieddu, MD, Mario Boccadoro, MD, Ernesto Capussela, MD, Antonella Vitale, MD, Giovanna Meloni, MD, Paola Fazzi, MD, PhD, Marco Vignetti, MD, Robert Foa, MD, Agostino Tafuri, MD

Blood (2006) 108 (11): 1843.

https://doi.org/10.1182/blood.V108.11.1843.1843

Published: 2006

NARROW

BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels

Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways

Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)

The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Protein Expression and Methylation Status of the CKI p21, p15 and p16 in Adult Acute Lymphoblastic Leukemia (ALL) Patients: Prognostic Implications.

Email alerts

ASH Publications

American Society of Hematology

BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels

Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways

Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)

The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.

Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Protein Expression and Methylation Status of the CKI p21, p15 and p16 in Adult Acute Lymphoblastic Leukemia (ALL) Patients: Prognostic Implications.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only